The efficacy of acupuncture in the treatment of chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis

Yi Zhao; Wendi Cao; Hengheng Zhang; Qingxi Rong; Mingxuan He; Meijie Wu; PING YANG

doi:10.1007/s11764-025-01869-3

journal article Aug 19, 2025

The efficacy of acupuncture in the treatment of chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis

Yi Zhao

Wendi Cao Hengheng Zhang

Qingxi Rong Mingxuan He Meijie Wu PING YANG

Journal of Cancer Survivorship · Springer Science and Business Media LLC

View at Publisher Save 10.1007/s11764-025-01869-3

Topics

No keywords indexed for this article. Browse by subject →

References

66

[1]

World Health Organization. Global health observatory data repository: cancer incidence and mortality trends, 2015–2020. Geneva: WHO; 2021.

[2]

World Health Organization. Global cancer burden growing, amidst mounting need for services. Saudi Med J. 2024;45(3):326–327.

[3]

Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Farkas L, Garrido-Laguna I, Grem JL, Gunn A, Hecht JR, Hoffe S, Hubbard J, Hunt S, Johung KL, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Gregory KM, Gurski LA. Colon cancer, version 2.2021, NCCN Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(3):329–359. https://doi.org/10.6004/jnccn.2021.0012. 10.6004/jnccn.2021.0012

[4]

American Cancer Chemotherapy Society. The role and significance of chemotherapy in cancer management. Philadelphia: Lippincott Williams & Wilkins; 2022.

[5]

Xichun Hu, Jin Li, Weijian G, et al. Chinese expert consensus on the prevention and treatment of chemotherapy-induced nausea and vomiting in common malignant tumors (2024 Edition). China Oncol. 2024;34(2):167–84.

[6]

Kannarkat G, Lasher EE, Schiff D. Neurologic complications of chemotherapy agents. Curr Opin Neurol. 2007;20(6):719–25. 10.1097/wco.0b013e3282f1a06e

[7]

Wang Y, Zhang L, Liu Y, et al. Insights into the Pathogenesis and Management of Chemotherapy - Induced Peripheral Neuropathy. Oncol Rev. 2023;17(2):155–67.

[8]

Jordan K, Broxterman H. Chemotherapy-induced peripheral neuropathy: mechanisms and diagnosis. Cancer Treat Rev. 2018;63:10–8.

[9]

Windebank A, Grisold W. Pathophysiology of chemotherapy-induced peripheral neuropathy. Nat Rev Neurol. 2017;13(1):15–24.

[10]

Smith A, Johnson B. Chemotherapy-induced peripheral neuropathy: clinical manifestations and impact on daily life. J Oncol Nurs. 2019;34(2):98–105.

[11]

Brown C, Davis D. Understanding the complexities of chemotherapy-induced peripheral neuropathy symptoms. Clinical Neurology Review. 2020;28(3):112–20.

[12]

Visovsky CV, Kirshner JJ. Chemotherapy - induced peripheral neuropathy: recognition, management, and prevention. Clin J Oncol Nurs. 2015;19(3):295–301.

[13]

Wilson E, Miller F. Epidemiology of chemotherapy-induced peripheral neuropathy: a systematic review. Cancer Epidemiol. 2021;45(2):167–78.

[14]

Green G, White H. Long-term outcomes of chemotherapy-induced peripheral neuropathy: a follow-up study. J Cancer Surviv. 2022;16(3):337–46.

[15]

Velasco R, Besora S, Argyriou AA, et al. Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience. Anticancer Drugs. 2021;32(1):88–94. 10.1097/cad.0000000000001005

[16]

Velasco R, Besora S, Argyriou AA, et al. Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world,open-label experience. Anticancer Drugs. 2021;32(1):88–94. 10.1097/cad.0000000000001005

[17]

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher, Alessandro Liberati, Jennifer Tetzlaff et al.

PLoS Medicine 2009 10.1371/journal.pmed.1000097

[18]

Yeh ML, Lin KC, Chen HH, et al. Use of traditional medicine and complementary and alternative medicine in Taiwan: a multilevel analysis. Holist Nurs Pract. 2015;29(2):87–95. 10.1097/hnp.0000000000000071

[19]

Wang X, Zhao N. Clinical observation of acupuncture intervention in chemotherapy-induced peripheral neuropathy patients. J Tradit Chin Med Rehabil. 2023;29(2):147–52.

[20]

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt et al.

BMJ 10.1136/bmj.n71

[21]

Higgins JPT, Green S (eds). Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The cochrane collaboration. 2011. https://doi.org/10.1002/9780470712184. 10.1002/9780470712184

[22]

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

J. P. T. Higgins, D. G. Altman, P. C. Gotzsche et al.

BMJ 2011 10.1136/bmj.d5928

[23]

Assessing the quality of reports of randomized clinical trials: Is blinding necessary?

Alejandro R. Jadad, R.Andrew Moore, Dawn Carroll et al.

Controlled Clinical Trials 1996 10.1016/0197-2456(95)00134-4

[24]

Moher D, Jadad AR, Nichol G, et al. Assessing the quality of randomized controlled trials: an annotated bibliography. Control Clin Trials. 1995;16(2):62–73. 10.1016/0197-2456(94)00031-w

[25]

Smith AB, Johnson CD, Brown EF, et al. Methodological approaches to analyzing chemotherapy-induced peripheral neuropathy outcomes: A systematic review and meta-analysis. J Clin Oncol. 2020;38(15):1745–56.

[26]

Measuring inconsistency in meta-analyses

Julian P T Higgins, Simon G Thompson, Jonathan J Deeks et al.

BMJ 2003 10.1136/bmj.327.7414.557

[27]

Bias in meta-analysis detected by a simple, graphical test

Matthias Egger, George Davey Smith, Martin Schneider et al.

BMJ 1997 10.1136/bmj.315.7109.629

[28]

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher, Alessandro Liberati, Jennifer Tetzlaff et al.

PLoS Medicine 2009 10.1371/journal.pmed.1000097

[29]

Stringer J, Ryder WD, Mackereth PA, et al. A randomised, pragmatic clinical trial of acupuncture plus standard care versus standard care alone for chemotherapy induced peripheral neuropathy (ACUFOCIN). Eur J Oncol Nurs. 2022;60: 102171. 10.1016/j.ejon.2022.102171

[30]

Molassiotis A, Suen LKP, Cheng HL, et al. A randomized assessor-blinded wait-list-controlled trial to assess the effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Integr Cancer Ther. 2019;18:1–12. 10.1177/1534735419836501

[31]

Lagerstedt K, Efverman A. A randomized sham-controlled mixed methods pilot study of the feasibility of acupuncture for chemotherapy-induced neuropathy: lessons learned from patient experiences in integrative cancer care. Integr Cancer Ther. 2023;22:1–14. 10.1177/15347354231178877

[32]

Han X, Wang L, Shi H, et al. Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma. BMC Cancer. 2017;17(1):40. 10.1186/s12885-016-3037-z

[33]

Lu WD, Giobbie-Hurder A, Freedman RA, et al. Acupuncture for chemotherapy-induced peripheral neuropathy in breast cancer survivors: a randomized controlled pilot trial. Oncologist. 2020;25(4):310–8. 10.1634/theoncologist.2019-0489

[34]

D’Alessandro EG, Nebuloni Nagy DR, Cecatto RB, et al. Acupuncture for chemotherapy-induced peripheral neuropathy: a randomised controlled pilot study. BMJ Support Palliat Care. 2019;0:1–92.

[35]

Friedemann T, et al. Acupuncture improves chemotherapy-induced neuropathy explored by neurophysiological and clinical outcomes-the randomized, controlled, cross-over ACUCIN trial. Phytomedicine. 2022;104: 154294. 10.1016/j.phymed.2022.154294

[36]

Huang MC, et al. Acupuncture may help to prevent chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled, single-blind study. Oncologist. 2023;28:e436–47. 10.1093/oncolo/oyad065

[37]

Zhang S, et al. Effect of electroacupuncture on chemotherapy-induced peripheral neuropathy in patients with malignant tumor: a single-blinded, randomized controlled trial. J Tradit Chin Med. 2017;37(2):179–84. 10.1016/s0254-6272(17)30042-0

[38]

Iravani S, et al. Effectiveness of acupuncture treatment on chemotherapy-induced peripheral neuropathy: a pilot, randomized, assessor-blinded, controlled trial. Pain Res Manag. 2020;2020:2504674. 10.1155/2020/2504674

[39]

Minton O, Higginson IJ. Electroacupuncture as an adjunctive treatment to control neuropathic pain in patients with cancer. J Pain Symptom Manage. 2007;33(2):11–117. 10.1016/j.jpainsymman.2006.09.011

[40]

Kim JH, et al. Electroacupuncture for chemotherapy-induced peripheral neuropathy: study protocol for a pilot multicentre randomized, patient-assessor-blinded, controlled trial. Trials. 2013;14: 254. 10.1186/1745-6215-14-254

[41]

Greenlee H, et al. Randomized sham controlled pilot trial of weekly electroacupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer. Breast Cancer Res Treat. 2016;156(3):453–64. 10.1007/s10549-016-3759-2

[42]

Rostock M, et al. Chemotherapy-induced peripheral neuropathy in cancer patients: A four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Altern Med. 2013;2013:349653. 10.1155/2013/349653

[43]

Lee JH, et al. Clinical study on concurrent use of electroacupuncture or Chuna manual therapy with pregabalin for chemotherapy-induced peripheral neuropathy: safety and effectiveness (open-labeled, parallel, randomized controlled trial, assessor-blinded): a study protocol. Medicine (Baltimore). 2020;99(3): e18830. 10.1097/md.0000000000018830

[44]

Bao T, et al. Effect of acupuncture vs sham procedure on chemotherapy-induced peripheral neuropathy symptoms: a randomized clinical trial. JAMA Netw Open. 2020;3(3):e200681. 10.1001/jamanetworkopen.2020.0681

[45]

Lu C, et al. Electroacupuncture with different frequencies for paclitaxel-induced peripheral neuropathy: a randomized controlled trial. Chin Acupunct Moxibustion. 2024;44(10):1139–45.

[46]

Bao T, et al. Health-related quality of life in cancer survivors with chemotherapy-induced peripheral neuropathy: a randomized clinical trial. Oncologist. 2021;26(11):e2070–8. 10.1002/onco.13933

[47]

Chemotherapy‐induced peripheral neuropathy: A current review

Nathan P. Staff, Anna Grisold, Wolfgang Grisold et al.

Annals of Neurology 2017 10.1002/ana.24951

[48]

Wolf S, Barton D, Kottschade L, et al. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008;44:1507–15. 10.1016/j.ejca.2008.04.018

[49]

Jin Y, Zhang R, Chen L, et al. Acupuncture for chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Integr Cancer Ther. 2023;22:153473542312068.

[50]

Du JY, Fang JQ, Liang Y, et al. Electroacupuncture attenuates mechanical allodynia by suppressing the spinal JNK1/2 pathway in a rat model of inflammatory pain. Brain Res Bull. 2014;108:27–36. 10.1016/j.brainresbull.2014.06.004

Showing 50 of 66 references

Metrics

4

Citations

66

References

Details

Published: Aug 19, 2025
License: View

Authors

Cite This Article

Yi Zhao, Wendi Cao, Hengheng Zhang, et al. (2025). The efficacy of acupuncture in the treatment of chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-025-01869-3

The efficacy of acupuncture in the treatment of chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis

You May Also Like